Pfizer and BioNTech Covid-19 vaccine approved by Singapore

▴ Pfizer and BioNTech Covid-19 vaccine approved by Singapore
Restrictions to be eases after Dec 28

Singapore has approved Pfizer-BioNTech's Covid-19 vaccine for pandemic use and expects delivery of the first shots by the end of December, Prime Minister Lee Hsien Loong said on Monday.

The city-state of 5.7 million expects to have enough vaccines for everyone by the third quarter of 2021, Lee added, and will make it free for all Singaporeans and long-term residents.

Lee said he and other government officials would be among the early recipients, after healthcare workers, frontline workers, the elderly and the vulnerable.


The prime minister also said that Singapore will progress to the third and final phase of its national Covid-19 response strategy on Dec 28, easing restrictions in the city-state of 5.7 million people where most days there are zero cases of local transmission.

Singapore will increase the maximum size of gatherings outside homes from five people to eight, and will ease capacity limits in public places like malls, attractions and at places of worship, he said.

“Please understand that even as we enter Phase three, the battle is far from won,” the prime minister said during a national address. “The Covid-19 virus has not been eradicated.”

Tags : #SingaporeApprovesCovidVaccine #PfizerCovidVaccine #BioNTech #SingaporeCovidNewsDec14

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024